Itekhnoloji yeAptar's Activ-Film™ yakhethwa ukukhusela uvavanyo olutsha lwe-SARS olukhawulezayo lwe-antigen yokuxilongwa kwe-COVID-19.

I-Crystal Lake, i-Illinois-(I-BUUSINESS WIRE)-Iqela le-Aptar, i-Inc. (i-New York Stock Exchange: i-ATR), inkokeli yehlabathi ekuhanjisweni kweziyobisi, ukuhanjiswa kwemveliso yabathengi kunye nezisombululo zokupakisha ezisebenzayo, ibhengeze ukuba iteknoloji ye-Activ-Film™ ikhethiwe. ukuze isetyenziswe Ukukhusela uvavanyo olutsha lwe-antigen olukhawulezayo lwe-SARS kwi-COVID-19, uvavanyo kutshanje lufumene isigunyaziso sosetyenziso olungxamisekileyo (EUA) oluvela kuLawulo lokuTya kunye neChiza lase-US (FDA).
Uvavanyo lwe-Antigen ye-Quidel® SARS luvavanyo lwe-antigen olukhawulezayo lokhathalelo oluphuhliswe yi-Quidel® Corporation, umenzi okhokelayo wezisombululo zezempilo, kwaye unokubonelela ngeziphumo zovavanyo kwimizuzu eyi-10.Uvavanyo lokufunda olubonakalayo alufuni naziphi na izixhobo ezincedisayo kwaye lubonelela ngofikelelo olwandisiweyo kuvavanyo olufikelelekayo noluchanekileyo lwe-COVID-19, oluya kunceda ukuhlangabezana neemfuno zovavanyo olungxamisekileyo kuqoqosho lwehlabathi, kubandakanywa iimfuno zovavanyo lweenkqubo zesikolo kunye nemimandla yasemaphandleni.
Itekhnoloji yeAptar CSP Technologies' Active-Film™ idityaniswe kwikhithi yokuxilonga ukuze ikhusele ukufuma kunye nezinye iimeko zokusingqongileyo ezinokuchaphazela ukuchaneka kovavanyo.I-Active-Film™ isebenzisa itekhnoloji ye-Aptar yesigaba sesithathu sobunini be-Activ-Polymer™, ebonelela ngokhuseleko lobunjineli obuqhelekileyo kwiindlela ezahlukeneyo zokujonga, njenge-Active-Vial™ ukulungiselela ukuhlalisa i-diagnostic dipstick kunye ne-Activ ehlanganiswe kwibhokisi yokuxilonga -Tab.Le teknoloji yokupakisha esebenzayo esekwe kwisayensi yezixhobo okwangoku isetyenziselwa ukukhusela i-electrochemical eyahlukeneyo, ukuhamba ngasemva kunye neekhithi zovavanyo lwe-molecular diagnostic kwimarike namhlanje.
UMongameli we-Aptar kunye ne-CEO uStephan B. Tanda uthe: "Siyavuya kakhulu ukusebenzisana ne-Quidel® Corporation kwesi sixhobo sibalulekileyo sokuxilonga kwaye sincede ukuzisa uvavanyo lwe-antigen lwe-Quidel® SARS emarikeni."Itekhnoloji yethu yezemathiriyeli yenzululwazi ye-Activ-Film ™ ikhusela imicu yovavanyo kwaye inceda ukunika iziphumo ezikhawulezayo nezithembekileyo.Siza kuqhubeka nokusebenza ngokubonelela ngezisombululo ezikhusela iikhithi zoxilongo ezibalulekileyo ze-COVID-19, kunye nezisombululo zokusasazwa kwamayeza kunye neemveliso zabathengi ezidingwa zizigidi zabantu yonke le mihla Injongo noxanduva eluntwini.
UBadre Hammond, uSekela Mongameli wezoRhwebo kwi-Aptar CSP Technologies, uqukumbele ngelithi: “Njengoko siqhubeka nokuphendula kwintlekele ye-COVID-19, esi sisombululo sitshintsha umdlalo siya kunceda ukuhlangabezana nesidingo esingxamisekileyo sovavanyo lwe-COVID-19 kuluntu kwihlabathi liphela.Sizibophelele ekuphuculeni ubuchule bethu bezesayensi ukwenza amaqabane ethu ahlangabezane nemfuno eqhubekayo yezisombululo ezitsha zokhathalelo lwempilo ukunceda ukuphucula nokusindisa ubomi. ”
I-Aptar yinkokeli yehlabathi kuyilo kunye nokwenziwa kokuhanjiswa kweziyobisi ezahlukeneyo, ukuhanjiswa kwemveliso yabathengi kunye nezisombululo zeziyobisi.Izisombululo ezintsha kunye neenkonzo ze-Aptar zibonelela ngeemarike ezahlukeneyo, kubandakanya amayeza, ubuhle, ukhathalelo lomntu, amakhaya, ukutya kunye neziselo.I-Aptar isebenzisa ingqiqo, uyilo, ubunjineli kunye nesayensi kunye netekhnoloji ukwenza itekhnoloji yokupakisha yokusasazwa, ubungakanani kunye nokukhusela kwiimpawu ezininzi eziphambili kwihlabathi, ngaloo ndlela izisa izibonelelo kwizigulana kunye nobomi babathengi, imbonakalo, impilo kunye namakhaya kwihlabathi liphela.Utshintsho kwintsingiselo.Ikomkhulu leAptar likwiCrystal Lake, eIllinois, kwaye inabasebenzi abazinikeleyo abangama-13,000 kumazwe angama-20.Ngolwazi oluthe vetshe, nceda undwendwele www.aptar.com.
Olu shicilelo lweendaba luqulethe iingxelo ezijonge phambili.Izenzi ezichazayo okanye ezizayo okanye ezinemiqathango (ezifana no “will”) zijolise ekuchongeni loo nkcazelo ijonge phambili.Iingxelo ezijonge phambili zenziwa ngokuhambelana nezibonelelo zezibuko ezikhuselekileyo zeCandelo le-27A yoMthetho we-Securities Act ka-1933 kunye neCandelo 21E loMthetho woTshintshiselwano lwe-Securities we-1934, kwaye zisekelwe kwiinkolelo zethu, iingcamango kunye nolwazi esinalo ngoku.Ngoko ke, ngenxa yeengozi ezaziwayo okanye ezingaziwayo kunye nokungaqiniseki kwimisebenzi yethu kunye nokusingqongileyo kwezoshishino, iziphumo zethu zokwenyani zinokwahluka ngokwezinto ezichazwe okanye ezichazwe kwiingxelo ezijonge phambili, kubandakanywa kodwa kungaphelelanga: ukuhlanganiswa okuyimpumelelo kokufunyanwa;Imo engqongileyo yolawulo;kunye nokhuphiswano, kubandakanywa inkqubela yezobuchwepheshe.Ngolwazi oluthe kratya malunga nale mingcipheko kunye neminye imingcipheko kunye nokungaqiniseki, nceda ujonge kwifayile yethu ye-US Securities and Exchange Commission, kubandakanywa "iMiciko yoMngcipheko" kunye "neNgxoxo yoLawulo kunye noHlalutyo lweeMeko zeMali kunye neziPhumo zokuSebenza kwiFomu ye-10-K."Ingxoxo phantsi.Kwaye iFom 10-Q.Asinasinyanzelo sokuhlaziya naziphi na iingxelo ezijonge phambili ngenxa yolwazi olutsha, iziganeko ezizayo okanye ezinye izizathu.
Investor Relations Contact: Matt DellaMaria matt.dellamaria@aptar.com 815-479-5530 Media Contact: Katie Reardon katie.reardon@aptar.com 815-479-5671
Investor Relations Contact: Matt DellaMaria matt.dellamaria@aptar.com 815-479-5530 Media Contact: Katie Reardon katie.reardon@aptar.com 815-479-5671


Ixesha lokuposa: Feb-25-2021